Flavio Ribichini, Gabriele Pesarini, Tommaso Fabris, Mattia Lunardi, Marco Barbierato, Gianpiero D'Amico, Chiara Zanchettin, Dario Gregori, Tommaso Piva, Elisa Nicolini, Caterina Gandolfo, Massimo Fineschi, Anna Sonia Petronio, Sergio Berti, Francesco Caprioglio, Francesco Saia, Rocco Sclafani, Giovanni Esposito, Fabrizio D'Ascenzo, Giuseppe Tarantini
The treatment of coronary artery disease (CAD) in patients with severe aortic valve stenosis (AVS) eligible for transcatheter aortic valve implantation (TAVI) is not supported by clinical evidence, and the role of physiology over anatomy as well as the timing of coronary intervention are not defined. FAITAVI (ClinicalTrials.gov: NCT03360591) is a nationwide prospective, open-label, multicentre, randomised controlled study comparing the angiography-guided versus the physiology-guided coronary revascularisation strategy in patients with combined significant CAD and severe AVS undergoing TAVI...
April 15, 2024: EuroIntervention